Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Affinity Chromatography based Endotoxin Removal Service

Introduction Mechanism Key Features Our Services Contact Us FAQs

Introduction

Endotoxins are integral components of the outer membrane of gram-negative bacteria that are shed during cell growth and death. In the biopharmaceutical industry, these molecules are invisible saboteurs because they are exceptionally heat-stable and resistant to standard pH extremes that would typically denature proteins. Affinity chromatography represents the gold standard for removing these contaminants. Affinity chromatography targets the specific molecular structure of the endotoxin itself. This ensures the removal of both aggregated and monomeric LPS, providing a level of purity essential for parenteral administration and sensitive in vitro research.

Our endotoxin removal service by affinity chromatography helps you obtain high-purity, clinical-grade biologicals through advanced ligand-specific matrices and optimized size-exclusion protocols. Creative Biolabs ensures your antibodies and recombinant proteins meet the most stringent regulatory standards for safety and efficacy.

Endotoxin removal by combining affinity chromatography and Triton X-114 (OA Literature)Fig.1 Endotoxin removal by combining affinity chromatography and Triton X-114.1

Mechanism of Affinity Chromatography to Remove Endotoxins

The efficacy of affinity chromatography lies in the high-precision interaction between a specialized ligand and the endotoxin molecule. By using a lock-and-key approach, the endotoxin remains firmly bound to the stationary phase (the resin), while the target protein flows through the column unharmed. This mechanism is effective even in complex buffers containing surfactants or serum, where traditional filtration methods often falter.

Lipid A Targeting

  • Most affinity ligands, such as Polymyxin B, exploit a high binding affinity for the Lipid A moiety, which is the toxic and highly conserved portion of the endotoxin molecule.

Dual-Action Binding

  • Modern ligands utilize a combination of ionic interactions, attracting the negatively charged phosphate groups of Lipid A, and hydrophobic interactions that "lock" onto the aliphatic fatty acid chains.

Key Features of Affinity Chromatography to Remove Endotoxins

Affinity-based endotoxin removal targets the specific molecular structure of the contaminant rather than relying on general physical properties like size or net charge. Affinity chromatography offers distinct advantages over ion-exchange or size-exclusion methods, which make this technology essential for biopharmaceutical purification.

Exceptional Selectivity

By adjusting the pore size (Mlim) of the matrix, proteins are excluded from the inner pores, while endotoxins bind to the external surface ligands.

High Binding Capacity

The matrices can handle heavy contamination, with capacities exceeding 1.5 x 109 EU/mL of resin.

Superior Recovery

Due to specific interaction to endotoxin, the method routinely achieves greater than 95% protein recovery, preserving the yield of high-value antibodies.

Broad pH and Salt Stability

This technology remains effective across a wide range of ionic strengths and neutral pH, making it compatible with most physiological buffers.

Ligand Stability

Advanced immobilization techniques prevent ligand leaching, ensuring that the final product is free from both endotoxins and purification chemicals.

Our Endotoxin Removal Service by Affinity Chromatography

Creative Biolabs provides a comprehensive, expert-led service designed to take your raw biological samples and transform them into ultra-pure, clinical-ready products. Our 20 years of experience allow us to customize the purification strategy based on the specific charge and hydrophobicity of your target protein. We specialize in handling sensitive monoclonal antibodies, recombinant vaccines, and radiopharmaceuticals, ensuring that endotoxin levels are reduced to <0.1 EU/mL.

  • Step 1: Endotoxin Quantitation
    Use the LAL assay to determine the baseline endotoxin concentration of your sample.
  • Step 2: Column Selection
    Based on protein's profile, select the optimal resin (e.g., Polymyxin B or Poly-lysine).
  • Step 3: Column Equilibration
    Equilibrate the system with pyrogen-free buffers.
  • Step 4: Affinity Adsorption
    The sample is passed through the column under controlled flow rates to maximize ligand-endotoxin contact time.
  • Step 5: Fraction Collection
    The purified protein is collected, ensuring maximum recovery.
  • Step 6: Final Analysis
    The eluate undergoes a LAL test to confirm the endotoxin levels.

Workflow of Our Endotoxin Removal Service by Affinity Chromatography.

Contact Us

Creative Biolabs is your dedicated partner in achieving the highest standards of biological purity. Our Endotoxin Removal by Affinity Chromatography service combines 20 years of expertise with cutting-edge ligand technology to ensure your biopharmaceuticals are safe, effective, and ready for the clinic. Contact us to discuss the specific requirements of your purification project.

FAQs

Can your service handle samples that contain high concentrations of salt or serum?

Yes. One of the strengths of affinity chromatography is its effectiveness in the presence of up to 10% serum and across wide ionic strengths, where other methods often fail.

Will the purification process denature my protein?

We use mild physiological conditions and non-toxic buffers to ensure your protein maintains its native structure and biological activity.

What is the lowest endotoxin level you can achieve?

We routinely reach levels below <0.1 EU/mL, which is the limit of detection for the most sensitive LAL assays.

Is there a risk of the ligand leaching into my final product?

No. We use stable, covalent immobilization techniques that ensure the ligand remains firmly attached to the resin matrix.

How do I know if affinity chromatography is right for my specific protein?

Our team provides a free initial consultation to review your protein's pI and hydrophobicity to determine the most effective purification strategy. Contact us to discuss your project.

Reference

  1. Silva, Filippo, et al. "Combined method to remove endotoxins from protein nanocages for drug delivery applications: the case of human ferritin." Pharmaceutics 13.2 (2021): 229. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/pharmaceutics13020229
Contact Us
© 2026 Creative Biolabs. All rights reserved.